Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
High dose rate brachytherapy source measurements intercomparison

Poder J, Smith RL, Shelton N, Whitaker M, Butler D, Haworth A

(2017), Australas Phys Eng Sci Med, 40(2), 377-83

DOI: 10.1007/s13246-017-0542-6

Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy

Beckman K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K

(2017), ANZ J Surg, 88(3), E183-8

DOI: 10.1111/ans.13954

An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review

Raymond E, O'Callaghan ME, Campbell J, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J

(2017), Radiat Oncol, 12, 56

DOI: 10.1186/s13014-017-0786-z

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period

Oberoi D, White V, Seymour J, Prince HM, Harrison S, Jefford M, Winship I, Hill D, Bolton D, Kay A, Millar J

(2017), J Cancer Surviv, 11(3), 329-38

DOI: 10.1007/s11764-016-0591-y

Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity

O'Callaghan ME, Raymond E, Campbell J, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K

(2017), Prostate Cancer Prostatic Dis, 20(4), 378-88

DOI: 10.1038/pcan.2017.28

Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity

O'Callaghan ME, Raymond E, Campbell JM, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K

(2017), Int J Radiat Oncol Biol Phys, 98(2), 318-37

DOI: 10.1016/j.ijrobp.2017.02.024

Activation of hip prostheses in high energy radiotherapy and resultant dose to nearby tissue

Keehan S, Smith RL, Millar J, Esser M, Taylor ML, Lonski P, Kron T, Franich RD

(2017), J Appl Clin Med Phys, 18(2), 100-5

DOI: 10.1002/acm2.12058

Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institution

Ong WL, Matheson B, Millar J

(2017), Brachytherapy, 16(2), 313-22

DOI: 10.1016/j.brachy.2016.11.010

Radiotherapy in anaplastic thyroid carcinoma: an Australian experience

So K, Smith RE, Davis SR

(2017), J Med Imaging Radiat Oncol, 61(2), 279-87

Advances in brachytherapy physics

Venselaar JLM, Beaulieu L, Chen Z, Smith RL

(2016), In: Godfrey DJ, Van Dyck J, Das SK, Curran BH and Wolbarst AB (eds), Advances in Medical Physics, Volume 6, Medical Physics Publishing, Wisconsin, USA,

GPs’ insights into prostate cancer diagnosis and care in regional Victoria, Australia

Ruseckaite R, Evans S, Millar J, Holton S, Mazza D, Fisher J, Kirkman M

(2016), Qual Rep, 21(12),

Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria

Evans SM, Patabendi Bandarage V, Kronborg C, Earnest A, Millar J, Clouston D

(2016), Prostate Int, 4(4),

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Millar J, Evans S

(2016), BMC Cancer, 16,

The normal tissue effects of microbeam radiotherapy: What do we know, and what do we need to know to plan a human clinical trial?

Smyth LM, Senthi S, Crosbie JC, Rogers PA

(2016), Int J Radiat Biol, 92(6),

Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia

Ruseckaite R, Sampurno F, Millar J, Frydenberg M, Evans S

(2016), BMC Urol, 16(1),

Two-dimensional scanning of PRESAGE® dosimetry using UV/VIS spectrophotometry and its potential application in radiotherapy

Youkahana EQ, Gagliardi F, Geso M

(2016), Biomed Phys Eng Express, 2(4),

Comparison of patient-reported quality-of-life and complications in men with prostate cancer, between two modes of administration

Sampurno F, Ruseckaite R, Millar JL, Evans SM

(2016), Clin Genitourin Cancer, 14(4),

Prospective evaluation of patient-reported quality of life outcomes after external beam radiation treatment for prostate cancer in Victoria: a cohort study by the Victorian Prostate Cancer Registry

Patabendi Bandarage VR, Billah B, Millar JL, Evans S

(2016), J Med Imaging Radiat Oncol, 60(3),

Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria

Sampurno F, Earnest A, Kumari PB, Millar JL, Davis ID, Murphy DG, Frydenberg M, Kearns PA, Evans SM

(2016), Med J Aust, 204(8),

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Duchesne GM, Woo HH, Bassett JK, Bowe SJ, D'Este C, Frydenberg M, King M, Ledwich L, Loblaw A, Malone S, Millar J, Milne R, Smith RG, Spry N, Stockler M, Syme RA, Tai KH, Turner S

(2016), Lancet Oncol, 17(6),

5 6 7 8 9